First in Human Phase I Dose Escalation Study of ALG.APV 527, a 5T4[...]
09/16/2024 | Press release | Distributed by Public on 09/16/2024 09:02
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact